These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9925152)

  • 21. The importance of performance evaluation in implementation of the Dialysis Outcomes Quality Initiative Guidelines.
    Steinberg EP
    Adv Ren Replace Ther; 1999 Jan; 6(1):36-41. PubMed ID: 9925148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. National Kidney Foundation-Dialysis Outcomes Quality Initiative.
    Am J Kidney Dis; 1997 Oct; 30(4 Suppl 3):S192-240. PubMed ID: 9339151
    [No Abstract]   [Full Text] [Related]  

  • 23. Reasons for producing guidelines on anemia of chronic renal failure: dialysis outcome quality initiative of the National Kidney Foundation.
    Triolo G; Canavese C; Di Giulio S
    Int J Artif Organs; 1998 Nov; 21(11):751-6. PubMed ID: 9894755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NKF-DOQI clinical practice guidelines for vascular access. National Kidney Foundation-Dialysis Outcomes Quality Initiative.
    Am J Kidney Dis; 1997 Oct; 30(4 Suppl 3):S150-91. PubMed ID: 9339150
    [No Abstract]   [Full Text] [Related]  

  • 25. Timing of dialysis initiation, duration and frequency of hemodialysis sessions, and membrane flux: a systematic review for a KDOQI clinical practice guideline.
    Slinin Y; Greer N; Ishani A; MacDonald R; Olson C; Rutks I; Wilt TJ
    Am J Kidney Dis; 2015 Nov; 66(5):823-36. PubMed ID: 26498415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. III. NKF-K/DOQI Clinical Practice Guidelines for Vascular Access: update 2000.
    Am J Kidney Dis; 2001 Jan; 37(1 Suppl 1):S137-81. PubMed ID: 11229969
    [No Abstract]   [Full Text] [Related]  

  • 27. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meeting the challenges of the new K/DOQI guidelines.
    Eknoyan G
    Am J Kidney Dis; 2003 Jun; 41(5 Suppl):3-10. PubMed ID: 12776308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New clinical practice guidelines for chronic kidney disease: a framework for K/DOQI.
    Patel SS; Kimmel PL; Singh A
    Semin Nephrol; 2002 Nov; 22(6):449-58. PubMed ID: 12430089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A journey in reversing practice patterns: a multidisciplinary experience in implementing DOQI guidelines for vascular access.
    Ackad A; Simonian GT; Steel K; Parisi C; Mancini S; Douglas C; Buckner D
    Nephrol Dial Transplant; 2005 Jul; 20(7):1450-5. PubMed ID: 15855211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coordination of care in disease management: opportunities and financial issues.
    Mosley C
    Semin Dial; 2000; 13(6):346-50. PubMed ID: 11130253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvements in dialysis patient mortality are associated with improvements in urea reduction ratio and hematocrit, 1999 to 2002.
    Wolfe RA; Hulbert-Shearon TE; Ashby VB; Mahadevan S; Port FK
    Am J Kidney Dis; 2005 Jan; 45(1):127-35. PubMed ID: 15696452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of nephrology nurses and technicians in the implementation of NKF-DOQI.
    Bender K; Swartz MD
    Nephrol News Issues; 1999 Apr; 13(4):21-3. PubMed ID: 10418445
    [No Abstract]   [Full Text] [Related]  

  • 34. Changes in the practice of angioaccess surgery: impact of dialysis outcome and quality initiative recommendations.
    Ascher E; Gade P; Hingorani A; Mazzariol F; Gunduz Y; Fodera M; Yorkovich W
    J Vasc Surg; 2000 Jan; 31(1 Pt 1):84-92. PubMed ID: 10642711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Considerations for optimal iron use for anemia due to chronic kidney disease.
    Hudson JQ; Comstock TJ
    Clin Ther; 2001 Oct; 23(10):1637-71. PubMed ID: 11726002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Dialysis Outcomes and Practice Patterns Study (DOPPS) and the Kidney Disease Outcomes Quality Initiative (K/DOQI): a cooperative initiative to improve outcomes for hemodialysis patients worldwide.
    Port FK; Eknoyan G
    Am J Kidney Dis; 2004 Nov; 44(5 Suppl 2):1-6. PubMed ID: 15486867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular Access Guidelines: Summary, Rationale, and Controversies.
    Sequeira A; Naljayan M; Vachharajani TJ
    Tech Vasc Interv Radiol; 2017 Mar; 20(1):2-8. PubMed ID: 28279405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Guideline-based medical quality management in dialysis. Motivation and structuring of a quality-management system and integration of earlier disease stages of chronic renal failure].
    Stoffel MP; Lauterbach KW; Baldamus CA
    Z Arztl Fortbild Qualitatssich; 2004 Oct; 98(7):609-16. PubMed ID: 15595603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The National Kidney Foundation Dialysis Outcomes Quality Initiative.
    Eknoyan G; Levin NW; Steinberg E
    Curr Opin Nephrol Hypertens; 1997 Nov; 6(6):520-3. PubMed ID: 9375263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacotherapy of end-stage renal disease.
    Schmid H; Schiffl H; Lederer SR
    Expert Opin Pharmacother; 2010 Mar; 11(4):597-613. PubMed ID: 20163271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.